Unique tau- and synuclein-dependent metabolic reprogramming in neurons distinct from normal aging

Area of Science:

• Neuroscience
• Metabolomics
• Aging Research

Background:

• Neuronal cells possess specialized metabolic profiles crucial for function.
• Metabolic reprogramming with age is linked to age-related diseases like Alzheimer's (AD) and Parkinson's (PD).
• The specific metabolic alterations in aging versus AD/PD neurons remain unclear.

Purpose of the Study:

• To investigate age-related and disease-specific metabolic changes in neurons.
• To differentiate metabolic profiles in normal aging, AD, and PD models.
• To explore therapeutic targets for neurodegenerative diseases based on metabolic dysregulation.

Main Methods:

• Utilized high-throughput steady-state metabolite profiling in Drosophila models.
• Analyzed wildtype Drosophila and Drosophila models of AD and PD.
• Investigated the impact of genetic targeting on metabolic pathways and neurodegenerative phenotypes.

Main Results:

• Found distinct metabolic pathway alterations in normal aging versus Tau or Synuclein overexpression.
• Identified dysregulation in purine and glutamate metabolism in both aging and disease states.
• Demonstrated partial rescue of neurodegenerative phenotypes by targeting these metabolic pathways.

Conclusions:

• Aging and Tau/Synuclein-driven metabolic reprogramming cooperate in AD pathogenesis (two-hit model).
• Targeting both aging- and disease-specific metabolic pathways presents a potential therapeutic strategy.
• Metabolic profiling in Drosophila provides insights into neurodegenerative disease mechanisms.